Predicting Chemotherapy Response to Paclitaxel-Based Therapy in Advanced Non-Small-Cell Lung Cancer with P-Glycoprotein Expression

Publisher： Karger

E-ISSN： 1423-0356|70|1|32-35

ISSN： 0025-7931

Source： Respiration, Vol.70, Iss.1, 2003-02, pp. : 32-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predicting Chemotherapy Response to Paclitaxel-Based Therapy in Advanced Non-Small-Cell Lung Cancer (Stage IIIb or IV) with a Higher T Stage (> T2)

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 173-179

Karger

Access to resources Recommend Favorite

Front-Line Paclitaxel/Cisplatin-Based Chemotherapy in Brain Metastases from Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 64, Iss. 1, 2002-12 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

New Drugs in the Palliative Chemotherapy of Advanced Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 416-421

Karger

Access to resources Recommend Favorite

Palliative Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Goals and Reality

By  

Oncology Research and Treatment, Vol. 22, Iss. 1, 1999-03 ,pp. : 63-64

Karger

Access to resources Recommend Favorite

Prognostic Value of Synaptophysin and Chromogranin A Expression in Patients Receiving Palliative Chemotherapy for Advanced Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 85, Iss. 4, 2012-04 ,pp. : 289-296

Karger

Access to resources Recommend Favorite